גמניל 1000 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

GEMCITABINE 1000 MG/VIAL

Verfügbar ab:

BIOAVENIR LTD

ATC-Code:

L01BC05

Darreichungsform:

POWDER FOR SOLUTION FOR INFUSION

Verabreichungsweg:

I.V

Hergestellt von:

VIANEX S.A, GREECE

Therapiegruppe:

GEMCITABINE

Anwendungsgebiete:

Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Berechtigungsdatum:

2012-06-01